| Mast cells in stress, pain, blood-brain barrier, neuroinflammation and Alzheimer’s disease D Kempuraj, S Mentor, R Thangavel, ME Ahmed, GP Selvakumar, ... Frontiers in cellular neuroscience 13, 448252, 2019 | 105 | 2019 |
| Targeted gene editing of glia maturation factor in microglia: a novel Alzheimer’s disease therapeutic target SP Raikwar, R Thangavel, I Dubova, GP Selvakumar, ME Ahmed, ... Molecular neurobiology 56, 378-393, 2019 | 58 | 2019 |
| Brain injury–mediated neuroinflammatory response and Alzheimer’s disease D Kempuraj, ME Ahmed, GP Selvakumar, R Thangavel, AS Dhaliwal, ... The Neuroscientist 26 (2), 134-155, 2020 | 57 | 2020 |
| Mast cell proteases activate astrocytes and glia-neurons and release interleukin-33 by activating p38 and ERK1/2 MAPKs and NF-κB D Kempuraj, R Thangavel, GP Selvakumar, ME Ahmed, S Zaheer, ... Molecular neurobiology 56, 1681-1693, 2019 | 57 | 2019 |
| NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson’s disease H Javed, R Thangavel, GP Selvakumar, I Dubova, N Schwartz, ... International immunopharmacology 83, 106441, 2020 | 36 | 2020 |
| Next generation precision medicine: CRISPR-mediated genome editing for the treatment of neurodegenerative disorders SP Raikwar, NS Kikkeri, R Sakuru, D Saeed, H Zahoor, K Premkumar, ... Journal of Neuroimmune Pharmacology 14, 608-641, 2019 | 29 | 2019 |
| Glia maturation factor and mast cell-dependent expression of inflammatory mediators and proteinase activated receptor-2 in neuroinflammation D Kempuraj, GP Selvakumar, R Thangavel, ME Ahmed, S Zaheer, ... Journal of Alzheimer's Disease 66 (3), 1117-1129, 2018 | 28 | 2018 |
| CRISPR/Cas9 editing of glia maturation factor regulates mitochondrial dynamics by attenuation of the NRF2/HO-1 dependent ferritin activation in glial cells GP Selvakumar, ME Ahmed, SP Raikwar, R Thangavel, D Kempuraj, ... Journal of Neuroimmune Pharmacology 14, 537-550, 2019 | 26 | 2019 |
| Synergy in disruption of mitochondrial dynamics by Aβ (1-42) and glia maturation factor (GMF) in SH-SY5Y cells is mediated through alterations in fission and fusion proteins ME Ahmed, GP Selvakumar, D Kempuraj, R Thangavel, S Mentor, ... Molecular neurobiology 56, 6964-6975, 2019 | 23 | 2019 |
| Neuro-immuno-gene-and genome-editing-therapy for Alzheimer’s disease: are we there yet? SP Raikwar, R Thangavel, I Dubova, ME Ahmed, PG Selvakumar, ... Journal of Alzheimer's Disease 65 (2), 321-344, 2018 | 22 | 2018 |
| A role for glia maturation factor dependent activation of mast cells and microglia in MPTP induced dopamine loss and behavioural deficits in mice GP Selvakumar, ME Ahmed, R Thangavel, D Kempuraj, I Dubova, ... Brain, behavior, and immunity 87, 429-443, 2020 | 21 | 2020 |
| Are Tanycytes the missing link between Type 2 Diabetes and Alzheimer’s Disease? SP Raikwar, SM Bhagavan, SB Ramaswamy, R Thangavel, I Dubova, ... Molecular neurobiology 56, 833-843, 2019 | 15 | 2019 |
| Molecular association of glia maturation factor with the autophagic machinery in rat dopaminergic neurons: a role for endoplasmic reticulum stress and MAPK activation GP Selvakumar, SS Iyer, D Kempuraj, ME Ahmed, R Thangavel, I Dubova, ... Molecular neurobiology 56, 3865-3881, 2019 | 11 | 2019 |
| Neuroinflammation Mediated by Glia Maturation Factor Exacerbates Neuronal Injury in an in vitro Model of Traumatic Brain Injury ME Ahmed, GP Selvakumar, D Kempuraj, SP Raikwar, R Thangavel, ... Journal of Neurotrauma 37 (14), 1645-1655, 2020 | 9 | 2020 |
| Glia Maturation Factor Dependent Mast Cell Activation and Calpain 1 Synergize Dopaminergic Neuronal Loss and Behavioral Deficits in an MPTP Mouse Model of Parkinson's Disease SG Pushpavathi, K Duraisamy, ME Ahmed, R Thangavel, I Dubova, ... The FASEB Journal 33 (S1), 791.7-791.7, 2019 | 2 | 2019 |
| Parkinson’s Disease Dementia Patients: Expression of Glia Maturation Factor in the Brain R Thangavel, H Kaur, I Dubova, GP Selvakumar, ME Ahmed, SP Raikwar, ... International Journal of Molecular Sciences 25 (2), 1182, 2024 | 1 | 2024 |
| P4‐509: SUPPRESSION OF NEUROINFLAMMATION AND AMYLOID PATHOLOGY IN 5XFAD MICE BRAIN BY GLIA MATURATION FACTOR ANTIBODY ME Ahmed, R Thangavel, GP Selvakumar, DP Kempuraj, IP Dubova, ... Alzheimer's & Dementia 15, P1508-P1508, 2019 | | 2019 |
| Glia Maturation Factor‐Antibody Injection Reduces Behavioral Impairment, Neuro Inflammation and Amyloid Pathology in 5XFAD Mice Brains ME Ahmed, R Thangavel, GP Selvakumar, D Kempuraj, I Dubova, ... The FASEB Journal 33 (S1), 791.1-791.1, 2019 | | 2019 |
| Glia Maturation Factor Gene Editing Improves Neurocognitive Function in an Alzheimer's Disease Mouse Model SP Raikwar, ME Ahmed, I Dubova, S Mentor, D Saeed, H Zahoor, ... The FASEB Journal 33 (S1), 620.10-620.10, 2019 | | 2019 |
| Engineering Micro-Indels in Glia Maturation Factor: a Novel Alzheimer's Disease Therapeutic Target SP Raikwar, R Thangavel, I Dubova, GP Selvakumar, ME Ahmed, G Giler, ... MOLECULAR THERAPY 26 (5), 139-140, 2018 | | 2018 |
